Donate For Public and Patients Store Search

U071 - Managing Challenging Alopecias: Preventing Hair Loss in CCCA, FFA, and Chemotherapy

Sunday, March 3; 4:30 PM - 5:30 PM

Learning Objectives

Following this course, the attendee should be able to:

  • Identify diagnostic features of early CCCA and FFA
  • Formulate a treatment plan to prevent progression of scarring alopecia
  • Perform a pre-chemotherapy alopecia consultation, and utilize scalp cooling (cold cap therapy) to prevent chemotherapy-induced alopecia

Description

Scarring alopecias present a treatment dilemma because they are often unrecognized until late in the disease course. In addition, chemotherapy induced alopecia is typically accepted as an expected outcome when undergoing breast cancer treatment. These alopecias can be devastating to patients and have long-lasting effects on quality of life. This session will focus on identifying and treating early scarring alopecias and will review the pre-chemotherapy alopecia consultation emphasizing scalp cooling (cold cap therapy) for treatment of chemotherapy-induced alopecia.

Disclosures

  • Mayo, Tiffany, MD: no financial relationships exist with commercial interests.
  • McMichael, Amy J., MD: Aclaris Therapeutics Inc. – C(H), I(Grants/Research Funding); Allergan, Inc. – C(H), I(OB); Anacor Pharmaceuticals, Inc. – A(H); Cassiopea S.p.A. – I(Grants/Research Funding); Concert Pharmaceuticals – I(Grants/Research Funding); Galderma Laboratories, L.P. – C(OB); Incyte Corporation – C(H), I(Grants/Research Funding); Informa – O(OB); JAMA – O(NC); Johnson & Johnson Consumer Products Company – C(H); NAAF – A(NC); North American Hair Research Society – B(NC); Procter & Gamble Company – C(H), I(OB); Samumed, LLC – C(H); UpToDate, Inc – Speaker/Faculty Education(H);
  • Olsen, Elise A., MD: Aclaris Therapeutics, Inc. – C(H), I(Grants/Research Funding); Allergan, Inc. – O(IP); Bioniz Therapeutics – C(H); Elorac, Inc. – I(Grants/Research Funding); Galderma USA – I(Grants/Research Funding); Helsinn Healthcare – O(H); Incyte Corporation – C(H); Lilly ICOS LLC – C(H); UpToDate, Inc – O(H);
Schedule
Sunday, March 3
4:30 PM
All faculty / Managing Challenging Alopecias: Preventing Hair Loss in CCCA, FFA, and Chemotherapy
Event Details
  • Date
    Sunday, March 3
  • Time
    4:30 PM - 5:30 PM
  • Location
    Room 102B
  • CME Credits
    1.00
  • Type
Directors/Co-Directors
Speakers
  • Amy J. McMichael, MD, FAAD
  • Elise A. Olsen, MD, FAAD